Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2024-09-02 Board/Management Inform…
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
代子公司中國化學製藥(股)公司公告 單一法人股東指派第27屆新任董事會成員
Board/Management Information Classification · 100% confidence The document is a formal announcement from a listed company (3716 中化控股) regarding the appointment of new board members and supervisors by a single corporate shareholder for its subsidiary, 中國化學製藥(股)公司. It details the names, titles, and backgrounds of outgoing and incoming directors and supervisors, the effective date of the changes, and related shareholding information. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting or voting results. The content clearly relates to changes in the company's board of directors and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short (1392 characters), consistent with a typical management change announcement rather than a full report.
2024-09-02 Chinese
代子公司中國化學製藥(股)公司公告第26屆新任董事會成員
Board/Management Information Classification · 100% confidence The document is a formal announcement from a listed company (3716 中化控股) regarding changes in the board members of its subsidiary, specifically the appointment and removal of directors and independent directors. It details the names, titles, and reasons for the changes, including dates and shareholdings. There is no financial data, no mention of financial results, no report attached or referenced, and the content focuses solely on management/board changes. This fits the definition of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a direct disclosure of board changes.
2024-09-02 Chinese
代子公司中國化學製藥(股)公司公告解任、發言人 代理發言人、公司治理主管、財務主管、會計主管 內部稽核主管
Board/Management Information Classification · 100% confidence The document is a company announcement regarding personnel changes, specifically the dismissal of various key roles such as spokesperson, proxy spokesperson, corporate governance officer, financial officer, accounting officer, and internal audit officer. It includes details about the old incumbents and the effective date of the changes. There is no financial data, no report attached or referenced, and no mention of financial results or regulatory filings beyond the personnel change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-09-02 Chinese
113年9月公開說明書 — 202507_3716_B1h2.pdf
Regulatory Filings
2024-09-02 Chinese
113年9月公開說明書 — 202507_3716_B1g.pdf
Regulatory Filings
2024-09-02 Chinese
113年9月公開說明書 — 202409_3716_B07.pdf
Regulatory Filings
2024-09-02 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.